Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_provenance.
- NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_assertion description "[mRNA levels of CD95L correlated positively (r=0.90; p< 0.01) and transmembrane CD95 inversely (r=-0.88; p< 0.01) with histopathological grading of the breast tumours: CD95L mRNA levels were low in adenomas, but increased by 20-fold in grade I, 120-fold in grade II, and 310-fold in grade III breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_provenance.
- NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_assertion evidence source_evidence_literature NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_provenance.
- NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_assertion SIO_000772 10547600 NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_provenance.
- NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_assertion wasDerivedFrom befree-20140225 NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_provenance.
- NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_assertion wasGeneratedBy ECO_0000203 NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP673539.RAhIL9nnfYbaxR0bVmhfVf3K1EfU38Dw7tFLzSoiVlXuI130_provenance.